Innovation
is the hallmark of growth and the progressive industry policy of our Government
has plenty of it. Just about an year ago, when I and the then Commissioner of
Industries Mr. Manickaraj, now collector of Sangareddy district presented a
case for such innovation, our Hon’ble Minister quickly endorsed it and added
his own input to make the investment in the clinic wide based with the MSME
participation. He is the first ever State Minister to visit the RBI with the
then Principal Secretary and Commissioner of Industries in October 2016 to
espouse the cause of aggrieved sector over the failure of the banks and
inadequate response from the regulator.
This
first state-promoted NBFC incorporated on the 7th of this month
headed by a very experienced CEO Mr. M. Sanjaya, former General Manager, Rural
Planning and Credit Dept of the RBI, stratgised its one hundred crore rupee
corpus fund with 10% seeding from the State Government through TSIDC into three
principal arms: Make in Telangana; Grow in Telangana; and Turn Around
Management with the support of research base, case studies, and strong advisory
and consulting support. A few of the banks have already shown interest in
contributing to the Corpus fund that promises 7% yield after a couple of years
of lock-in period.
Micro
and small manufacturing enterprises in the state have little start-up funding
and no more than 2% of turn-around management.
This diagnostic and curative clinic provides
responsible and responsive consultancy and hand-holding support to ward off the
compliance risks of banks in start-ups and revival. The incipient sick will be
provided bridge finance to prevent sickness as decided by the Board.
The
TIHCL targets on average five to ten enterprises per month per district during
the coming year providing employment to around 5000 persons.
Just
one service sector Small enterprise from our state is listed on the SME
Exchange for the last six years of its existence. In order to encourage the
manufacturing Small enterprises running on profits with good product range for
the last 3 years to move to the equity markets our Clinic in coordination with
NSE-EDGE and BSE and after proper due diligence will participate to an extent
of 10% of the issue up to a maximum of Rs.50 lakhs. During the first year ten enterprises
are targeted.
Employment,
growth and zero-NPA MSEs in manufacturing are our targets. An independent Board
with professionals will drive these initiatives. The country has no parallel
elsewhere. At a time when NPAs and distressed assets are bugging the banking
industry and Government of India our Government with this initiative will be
the torch bearer for the MSE sector.
No comments:
Post a Comment